STRO Market Cap History



Below is a table of the STRO market cap history going back to 9/27/2018:

Date STRO Market Cap
9/27/2018336.78M
11/9/2018306.39M
3/27/2019242.55M
5/10/2019263.64M
8/8/2019235.01M
8/6/2019131.35M
11/4/2019239.21M
3/9/2020199.34M
5/1/2020220.20M
7/30/2020285.96M
10/30/2020496.45M
3/11/20211.05B
4/29/2021964.22M
8/3/2021826.04M
11/4/20211.09B
2/24/2022409.08M
5/4/2022306.48M
8/4/2022286.37M
11/3/2022423.59M
3/27/2023282.75M
5/11/2023329.88M
8/7/2023251.19M
11/8/2023148.12M
3/20/2024212.30M

Also see: STRO Shares Outstanding History
and STRO YTD Return
STRO Historical Market Cap:
-8.07% CAGR
STRO Historical Market Cap: +-8.07% CAGR

Mouse over chart for data details
9/27/2018 ...3/20/2024
Sutro Biopharma is a clinical-stage oncology company developing site-specific and antibody drug conjugates (ADCs) enabled by its proprietary integrated cell-free protein synthesis platform, XpressCF®, and its site-specific conjugation platform, XpressCF+®. Co.'s product candidate is STRO-002, or luveltamab tazevibulin, an ADC directed against folate receptor-alpha (FolRa) for patients with FolRa-expressing cancers, including ovarian cancer. Co.'s other product candidate is STRO-001, an ADC directed against CD74, for patients with B-cell malignancies, such as multiple myeloma and non-Hodgkin lymphoma. Co. also has a preclinical product candidate, STRO-003, which is a single homogeneous ADC. We show 24 historical shares outstanding datapoints in our STRO shares outstanding history coverage, used to compute STRO market cap on those dates.

Understanding the changing numbers of shares outstanding, the changing share price, and the resulting changing STRO market cap history over the course of time is important for investors interested in comparing STRO's market cap history versus its peers. Many "beginner" or "novice" investors will look at one stock trading at a price of $10 per share and another trading at a price of $20 per share and think the latter company is worth twice as much. Of course, that is a completely meaningless comparison without also knowing how many shares outstanding there are for each of the two companies, and then calculating their respective market caps. Comparing the share price of STRO versus a peer is one thing; comparing STRO market cap versus a peer is a completely different story. Furthermore, via fluctuation both in per-share price and in the number of shares outstanding (via issuance of new shares over time, the repurchase of existing shares), the market cap for a company like STRO can fluctuate over the course of history. With this page we aim to empower investors researching STRO by allowing them to research the STRO market cap history.
Quotes delayed 20 minutes

Email EnvelopeFree STRO Email Alerts:
Get Dividend Alerts
Get SEC Filing Alerts
10 Most Oversold Stocks in the S&P
10 Most Overbought Stocks in the S&P
10 ETFs With Stocks That Insiders Are Buying
10 ETFs With Most Upside To Analyst Targets
The DividendRank Top 25
Warren Buffett Dividend Stocks
10 Cheap Dividend Stocks Under $10
10 Energy Stocks You Can Buy Cheaper Than Insiders Did
10 Top DividendRank'ed Energy Stocks
The 10 Highest Yielding Preferred Stocks
The 10 Highest Yielding Preferred Stocks
The 15 Most Active Call & Put Options of the S&P 500 Components
Video: The Importance of Market Cap


If the video does not load after a few moments, Upgrade to the Latest Flash Player.
Sutro Biopharma (STRO) is categorized under the Healthcare sector; to help you further research historical market cap numbers, below are some other companies in the same sector:

STRR Market Cap History
STSA Market Cap History
STSS Market Cap History
STTK Market Cap History
SUPN Market Cap History
SURF Market Cap History
SVA Market Cap History
SVRA Market Cap History
SWAV Market Cap History
SWTX Market Cap History
More Healthcare companies »

 

STRO Market Cap History | www.MarketCapHistory.com | Copyright © 2017 - 2024, All Rights Reserved

Nothing in MarketCapHistory.com is intended to be investment advice, nor does it represent the opinion of, counsel from, or recommendations by BNK Invest Inc. or any of its affiliates, subsidiaries or partners. None of the information contained herein constitutes a recommendation that any particular security, portfolio, transaction, or investment strategy is suitable for any specific person. All viewers agree that under no circumstances will BNK Invest, Inc,. its subsidiaries, partners, officers, employees, affiliates, or agents be held liable for any loss or damage caused by your reliance on information obtained. By visiting, using or viewing this site, you agree to the following Full Disclaimer & Terms of Use and Privacy Policy. Video widget and market videos powered by Market News Video. Quote and option data delayed at least 15 minutes; stock quote data powered by Ticker Technologies, and Mergent.
X
Wait! Don't leave yet.
Want to receive our latest research absolutely free?


Click the button below for your complimentary copy of Your Early Retirement Portfolio: Dividends Up to 9.5%—Every Month—Forever.

You'll discover the details on 4 stocks and funds that pay you massive dividends as high as 9.5%.